• Halazone and Oxidant Effects on Sodium Channel Inactivation

  2026-07-06

  This article examines a pivotal study on how Halazone and related oxidants modulate sodium current inactivation in voltage-clamped myelinated frog nerve fibers. The findings challenge prior assumptions about amino acid residue involvement and suggest membrane lipid modification as a key mechanism, with implications for neurophysiology and antimicrobial sulfonamide research.

• MDM1 Overexpression Enhances p53-Mediated Apoptosis in CRC T

  2026-07-06

  This study reveals that MDM1 overexpression in colorectal cancer (CRC) cells promotes p53 expression and apoptosis, improving sensitivity to chemoradiotherapy. These findings position MDM1 as a promising predictive biomarker for treatment response and suggest new avenues for optimizing therapeutic strategies in CRC.

• Rottlerin (SKU B6803): Best Practices for Reliable PKC Inhib

  2026-07-05

  This article provides an evidence-based guide for optimizing cell viability and apoptosis assays using Rottlerin (SKU B6803), a selective PKC inhibitor from APExBIO. Through five real-world laboratory scenarios, we address challenges in experimental design, protocol optimization, data interpretation, and vendor selection, ensuring that biomedical researchers can achieve reproducible, high-sensitivity results.

• Parathyroid hormone (1-34) (human): Precision for Bone & Kid

  2026-07-04

  Parathyroid hormone (1-34) (human) is transforming advanced bone metabolism and kidney disease research by enabling high-fidelity, receptor-specific assays that recapitulate core in vivo mechanisms. Its validated performance and reproducible effects empower translational workflows that bridge molecular signaling and disease modeling. Leverage APExBIO’s rigorously characterized peptide for unrivaled experimental reliability.

• IPR-803 and the Next Frontier in Tumor Microenvironment Modu

  2026-07-03

  This thought-leadership article unpacks the mechanistic and translational significance of IPR-803, a competitive urokinase receptor inhibitor, within the evolving landscape of tumor microenvironment targeting. By weaving together recent mechanistic insights, validated protocols, and strategic outlooks, the article offers translational researchers a blueprint for leveraging IPR-803 in preclinical and emerging nanomedicine workflows—especially for breast and pancreatic cancer. Beyond summarizing current evidence, the discussion highlights how IPR-803 enables a paradigm shift from mere cytotoxicity to stroma and angiogenesis modulation, referencing recent advances in sequential nanomedicine delivery and offering practical guidance for experimental design.

• Translatome Remodeling Links Fasting, Ketogenesis, and Tumor

  2026-07-03

  Yang et al. (2024) reveal that fasting induces selective remodeling of hepatic mRNA translation through the AMPK-MNK-eIF4E axis, controlling ketogenesis and exposing metabolic vulnerabilities in pancreatic tumors. This study uncovers a direct molecular bridge between diet, translational control, and cancer therapy, with implications for targeting the MNK-eIF4E signaling pathway.

• Structural Insights into ASCH Domains and N4-Acetylcytidine

  2026-07-02

  Meng et al. provide the first detailed structural and mechanistic analysis of ASCH domain-containing proteins, revealing that EcYqfB specifically hydrolyzes free N4-acetylcytidine (ac4C) nucleoside but does not remove ac4C from RNA. This work clarifies substrate specificity among ASCH homologs and advances understanding of nucleotide processing in RNA epigenetics research.

• Triamcinolone Protocol Guidance for Glucocorticoid Research

  2026-07-02

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist designed for in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This compound is not suitable for diagnostic or clinical use and demands strict attention to solubility, handling, and storage to ensure data integrity.

• BMS-777607: c-Met Inhibitor Enhances Stem Cell Platelet Prot

  2026-07-01

  BMS-777607, a highly selective c-Met inhibitor, empowers researchers to precisely modulate MET signaling in both cancer and stem cell-derived platelet models. Its integration into hiPSC-to-megakaryocyte workflows accelerates maturation, boosts yield, and offers new cost-effective strategies for scalable platelet production.

• Practical Guide: DiI (DiIC18(3)) Plasma Membrane Orange Fluo

  2026-07-01

  DiI (DiIC18(3)) enables precise, high-contrast plasma membrane labeling in both live and fixed biological systems. It is ideal for neuronal tracing and cell migration workflows but should be avoided in aqueous protocols or for non-membrane organelle labeling. Proper preparation, solubility management, and workflow-specific controls are critical for reproducibility.

• Lactobacillus gasseri Modulates Colitis via E-cadherin Regul

  2026-06-30

  This study demonstrates that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis by regulating E-cadherin expression through the NR1I3 pathway, highlighting a novel mechanism for probiotic intervention in intestinal barrier function. The findings offer mechanistic insights for gut barrier research and suggest new directions for therapeutic strategies targeting inflammatory bowel disease (IBD).

• Nigericin Sodium Salt: Practical Protocols for Ion Transport

  2026-06-30

  Nigericin sodium salt is a potassium ionophore designed for targeted manipulation of ion gradients and cytoplasmic pH in cell-based assays. Its strengths include selectivity for K+/H+ exchange and application in platelet aggregation and lead ion transport studies. Researchers should avoid using it in long-term or aqueous workflows due to stability and solubility constraints.

• BMS-777607: Advanced c-Met Inhibitor for Platelet and Cancer

  2026-06-29

  BMS-777607 delivers precise MET signaling pathway inhibition for both hiPSC-derived platelet differentiation and cancer metastasis research. Its selectivity and versatility empower researchers to optimize protocols, boost efficiency, and overcome long-standing experimental bottlenecks.

• HyperScript First-Strand cDNA Synthesis Kit: Precision in Co

  2026-06-29

  The HyperScript First-Strand cDNA Synthesis Kit delivers unmatched efficiency in first-strand cDNA synthesis from total or poly(A)+ RNA, excelling with complex secondary structures and low-copy transcripts. Applied workflows, recent reference breakthroughs, and actionable troubleshooting position this APExBIO product as a front-runner for robust PCR and qPCR studies.

• Cryo-EM Reveals Structural Diversity in Full-Length Human αv

  2026-06-28

  This study presents high-resolution cryo-EM structures capturing multiple conformations of full-length human integrin αvβ3, including five previously uncharacterized intermediate states. These findings advance our understanding of integrin activation mechanisms, informing the rational design of more precise and effective integrin-targeted therapeutics.

9226 records 1/616 page Next 12345 下5页 Last page